Authors


Jeannette Y. Wick, MBA, RPh, FASCP

Latest:

Are Nonhallucinogenic Psychedelics a Pharmacy Oxymoron?

The pipeline of hallucinogenic and nonhallucinogenic psychedelic medicines is exploding.


Raven Jackson, PharmD, Candace Hopgood, PharmD, Vy Nguyen, PharmD

Latest:

How Will Pharmacists Practice in 2015: A 2017 Response

Pharmacists must continue to evolve to the needs of their patients and always remain a key player in health care decisions.


Keith Hasson

Latest:

Fraud Cases Underscore New Challenges for Compounding Pharmacies

Compounded drugs accounted for more than half of cost increases under Medicare Part D in the last year.


Debra A. Bowers, BA

Latest:

Comparison of Pharmacists and Primary Care Providers as Immunizers

Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.



Anne Marie (Sesti) Kondic, PharmD

Latest:

Look and Look Again -- Getting to Know the Community Pharmacy Foundation

Although its organizational infrastructure is virtual, the Community Pharmacy Foundation (CPF) is ‘anything but’ and is quite quantifiable and impactful in its vision, mission, and deliverables.



Melinda J. Throm, PharmD, BCPS

Latest:

Continuity of Care: Diabetic Neuropathy: Bridging the Sensation Gap

Pharmacists in all health care settings play an important role in the prevention and treatment of diabetic neuropathy.


Douglas C. Higgins, RPh, FIACP

Latest:

USP Chapter : Nonsterile Compounding Pharmacy Air Flow Considerations

USP Chapter presents many challenges for pharmacies and other health care settings, especially compounding pharmacies.



David Hughes, PharmD, BCOP

Latest:

A New Monoclonal Antibody for R/R MM: Isatuximab-irfc

Isatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.


Gregory Burger, MS, RPh, FASHP

Latest:

Drug Diversion: New Approaches to an Old Problem

Drug diversion in hospitals continues to be problematic. Heightened DEA activity and opioid addiction reaching epidemic proportions require hospitals to be more vigilant than ever.



Royce Burruss, RPh, MBA, FASCP

Latest:

The Changing Clinical Assessment: An Overview and Next-Level Challenges

The clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.




Mischa Pesicek, PharmD

Latest:

Walmart Essay Winner: A Community Pharmacist's Impact Can Go a Long Way

"The total time that I spent with this man was less than 20 minutes, but the impact that I had on his life when he thought he was all alone will last a lifetime."






Benjamin Chastek, MS

Latest:

Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis Patients

Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.


Stephanie Watson, PharmD Candidate

Latest:

Unanticipated Learning Opportunities for Pharmacy Students During COVID-19

The coronavirus disease 2019 pandemic has presented pharmacy students with an opportunity to develop new skills that former students never had the opportunity to develop.


Joanne LaFleur, PharmD, MSPH

Latest:

Biopharmaceuticals: A Way Forward for Biogenerics?

Although the demand for generic competition in the biopharmaceutical market could potentially be great, regulators have been slow to clear a pathway for the approval of generic biopharmaceuticals.


By Aimee Simone, Pharmacy Times Assistant Editor

Latest:

Specialty Pharmacies May Improve Care for Hemophilia, vWD Patients

To improve the care of patients with hemophilia and von Willebrand's Disease (vWD), coagulation factor products should be billed through the pharmacy benefit and provided by specialty pharmacies, the authors of a new study suggest.


Huabin F. Zhang, MD, MPH

Latest:

Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic Therapies

Among psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.



David Schaaf, MD

Latest:

Understanding Predictors of Opioid Abuse: Predictive Model Development and Validation

This study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.


Aimee Simone, Associate Editor

Latest:

New on the Job: Dos and Don'ts

These tips can help recent pharmacy school graduates navigate the professional world.